Takeda Pharmaceutical Ownership | Who Owns Takeda Pharmaceutical?
Takeda Pharmaceutical Ownership Summary
Takeda Pharmaceutical is owned by 3.35% institutional investors, 0.06% insiders, and 96.59% retail investors. Capital research global investors is the largest institutional shareholder, holding 0.62% of TAK shares. Capital Group American Mutual Comp is the top mutual fund, with 0.57% of its assets in Takeda Pharmaceutical shares.
TAK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Takeda Pharmaceutical | 3.35% | 0.06% | 96.59% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 37.12% | 13.99% | 48.89% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Capital research global investors | 19.30M | 0.62% | $309.34M |
| Fmr | 9.60M | 0.31% | $153.88M |
| Morgan stanley | 6.99M | 0.22% | $112.13M |
| Adage capital partners gp | 6.05M | 0.19% | $96.99M |
| Goldman sachs group | 5.13M | 0.16% | $82.15M |
| Brandes investment partners, lp | 4.54M | 0.15% | $72.77M |
| Arrowstreet capital, limited partnership | 3.73M | 0.12% | $59.84M |
| Blackrock funding, inc. /de | 3.69M | 0.12% | $59.12M |
| Blackrock | 1.44M | 0.09% | $18.59M |
| Renaissance | 2.57M | 0.08% | $41.17M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Managed asset portfolios | 1.82M | 3.34% | $29.24M |
| Clean yield group | 227.99K | 0.91% | $3.65M |
| Pfm health sciences, lp | 444.17K | 0.61% | $7.12M |
| Legacy wealth asset management | 160.17K | 0.56% | $2.57M |
| Brandes investment partners, lp | 4.54M | 0.51% | $72.77M |
| Gold investment management | 105.85K | 0.46% | $1.70M |
| Carrera capital advisors | 167.17K | 0.40% | $2.73M |
| First affirmative financial network | 41.85K | 0.29% | $612.71K |
| Dorsey wright & associates | 94.28K | 0.26% | $1.51M |
| Fortress financial group | 231.00 | 0.21% | $390.57M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 9.60M | 0.01% | 2.48M |
| Qube research | 2.21M | 0.03% | 2.21M |
| Millennium management | 1.05M | 0.01% | 1.05M |
| Aqr capital management | 1.53M | 0.01% | 631.26K |
| Sixth street partners management company | 619.02K | 0.00% | 619.02K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 911.32K | 0.00% | -1.83M |
| Soleus capital management | - | - | -1.18M |
| Voloridge investment management | - | - | -962.50K |
| Capital wealth planning | - | - | -886.84K |
| Toronto dominion bank | - | - | -823.20K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sixth street partners management company | 619.02K | 0.00% | 619.02K | $9.92M |
| Cowen and company | 530.60K | 0.19% | 530.60K | $6.87M |
| Pfm health sciences, lp | 444.17K | 0.61% | 444.17K | $7.12M |
| Hudson bay capital management lp | 275.00K | 0.01% | 275.00K | $4.41M |
| Nuveen | 174.36K | 0.00% | 174.36K | $2.79M |
Sold Out
| Holder | Change |
|---|---|
| Lloyd advisory services, llc. | -1.00 |
| Northwest financial advisors | -1.00 |
| Rise advisors | -1.00 |
| West branch capital | -3.00 |
| Point72 asia (singapore) pte. | -3.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 381 | 4.10% | 104,834,614 | 6.74% | 3 | 33.96% | 210 | -8.30% | 99 | 62.30% |
| Mar 31, 2026 | 354 | 0.85% | 97,837,706 | 16.83% | 3 | 44.08% | 223 | 38.51% | 60 | -52.76% |
| Dec 31, 2025 | 209 | -37.61% | 39,526,007 | -53.64% | 1 | 16.85% | 82 | -58.16% | 84 | 12.00% |
| Sep 30, 2025 | 203 | -33.88% | 18,053,624 | -72.33% | - | 3.49% | 110 | -39.56% | 45 | -28.57% |
| Jun 30, 2025 | 309 | -0.32% | 77,823,025 | 9.47% | 4 | 24.04% | 185 | 9.47% | 63 | -29.21% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Capital Group American Mutual Comp | 18.16M | 0.57% | - |
| American Funds American Mutual A | 18.16M | 0.57% | - |
| First Trust Value Line® Dividend ETF | 1.93M | 0.06% | -1.68K |
| VanEck Pharmaceutical ETF | 1.65M | 0.05% | -29.42K |
| Capital Group American Mutual Trust U0 | 1.14M | 0.04% | 193.46K |
| MAP Global Equity Composite | 912.96K | 0.03% | 10.85K |
| Mondrian Int Eq Delivered Strategy | 816.00K | 0.03% | -1.77M |
| Steward Values Enhanced International I | 711.87K | 0.02% | - |
| Steward International Enhanced Index I | 651.53K | 0.02% | 315.75K |
| Mercer Non-US Core Equity Y3 | 586.10K | 0.02% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 02, 2026 | Plump Andrew Stewart | President, R&D | Sell | $2.15M |
| Aug 19, 2026 | Plump Andrew Stewart | President, R&D | Sell | $363.35K |
| Aug 18, 2026 | Greenway Nicola Deidre Petal | Chief Human Resources Officer | Sell | $235.12K |
| Aug 10, 2026 | Farajallah Awny Samaan Botros | Chief Medical Officer | Sell | $239.50K |
| Aug 10, 2026 | Ibrahim Ramy Riad Ahmed | President, PDT BU | Sell | $124.44K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2028 Q2 | - | - |
| 2028 Q1 | - | - |
| 2026 Q1 | - | - |
| 2022 Q4 | - | - |
TAK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools